MCID: DSS010
MIFTS: 33

Dissociative Disorder

Categories: Mental diseases

Aliases & Classifications for Dissociative Disorder

MalaCards integrated aliases for Dissociative Disorder:

Name: Dissociative Disorder 12 15 73
Dissociative Disorders 44
Dissociative Reaction 12
Dissociative Disease 12

Classifications:



External Ids:

Disease Ontology 12 DOID:10935
ICD10 33 F44.9 F48.9 F44
ICD9CM 35 300.15 300.9
MeSH 44 D004213
NCIt 50 C92197
SNOMED-CT 68 44376007

Summaries for Dissociative Disorder

Disease Ontology : 12 A disease of mental health in which the normally well-integrated functions of memory, identity, perception, or consciousness are separated (dissociated).

MalaCards based summary : Dissociative Disorder, also known as dissociative disorders, is related to dissociative amnesia and multiple personality disorder. An important gene associated with Dissociative Disorder is TNFSF11 (TNF Superfamily Member 11). The drugs Ranibizumab and Triamcinolone have been mentioned in the context of this disorder. Affiliated tissues include brain, amygdala and testes.

Wikipedia : 76 Dissociative disorders (DD) are conditions that involve disruptions or breakdowns of memory, awareness,... more...

Related Diseases for Dissociative Disorder

Diseases related to Dissociative Disorder via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 27)
# Related Disease Score Top Affiliating Genes
1 dissociative amnesia 32.0 TNFSF11 AANAT
2 multiple personality disorder 31.6 TNFSF11 PDLIM4 DPM1
3 conversion disorder 11.5
4 depersonalization disorder 11.3
5 dissociative seizures 11.0
6 personality disorder 10.1
7 borderline personality disorder 10.0
8 anxiety 9.9
9 obsessive-compulsive disorder 9.9
10 schizophrenia 9.9
11 post-traumatic stress disorder 9.9
12 depression 9.9
13 attention deficit-hyperactivity disorder 9.6
14 brain injury 9.6
15 hemangioma 9.6
16 traumatic brain injury 9.6
17 epilepsy 9.6
18 dermatitis 9.6
19 capillary hemangioma 9.6
20 mood disorder 9.6
21 gastritis 9.6
22 hyperglycemia 9.6
23 neurotic disorder 9.6
24 panic disorder 9.6
25 acute disseminated encephalomyelitis 9.6
26 hyperthyroidism 9.6
27 encephalitis 9.6

Graphical network of the top 20 diseases related to Dissociative Disorder:



Diseases related to Dissociative Disorder

Symptoms & Phenotypes for Dissociative Disorder

Drugs & Therapeutics for Dissociative Disorder

Drugs for Dissociative Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 108)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ranibizumab Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 347396-82-1 459903
2
Triamcinolone Approved, Vet_approved Phase 4,Phase 3,Not Applicable 124-94-7 31307
3
Sertraline Approved Phase 4 79617-96-2 68617
4
Rasagiline Approved Phase 4 136236-51-6 3052776
5
Verteporfin Approved, Investigational Phase 4,Not Applicable 129497-78-5
6 Serotonin Agents Phase 4,Not Applicable
7 Antidepressive Agents Phase 4
8 Neurotransmitter Uptake Inhibitors Phase 4,Not Applicable
9 Neurotransmitter Agents Phase 4,Phase 2,Phase 3,Not Applicable
10 Psychotropic Drugs Phase 4,Phase 3,Phase 2,Not Applicable
11 Serotonin Uptake Inhibitors Phase 4,Not Applicable
12 Angiogenesis Modulating Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
13 Angiogenesis Inhibitors Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
14 Immunologic Factors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
15 triamcinolone acetonide Phase 4,Phase 3,Not Applicable
16 Immunosuppressive Agents Phase 4,Phase 3
17 Triamcinolone hexacetonide Phase 4,Phase 3,Not Applicable
18 Triamcinolone diacetate Phase 4,Phase 3,Not Applicable
19 Neuroprotective Agents Phase 4
20 Monoamine Oxidase Inhibitors Phase 4
21 Protective Agents Phase 4
22 Photosensitizing Agents Phase 4,Not Applicable
23 Dermatologic Agents Phase 4,Not Applicable
24
Serotonin Investigational, Nutraceutical Phase 4,Not Applicable 50-67-9 5202
25
Heparin Approved, Investigational Phase 3 9005-49-6 772 46507594
26
Dalteparin Approved Phase 3 9005-49-6
27
Fluorouracil Approved Phase 3 51-21-8 3385
28
Propranolol Approved, Investigational Phase 2, Phase 3 525-66-6 4946
29
Povidone Approved Phase 3 9003-39-8
30
Bevacizumab Approved, Investigational Phase 3,Phase 2,Phase 1,Not Applicable 216974-75-3
31
Iodine Approved, Investigational Phase 3 7553-56-2 807
32
Povidone-iodine Approved Phase 3 25655-41-8
33
Lidocaine Approved, Vet_approved Phase 3 137-58-6 3676
34
Temazepam Approved, Investigational Phase 3,Phase 2,Not Applicable 846-50-4 5391
35 Calcium, Dietary Phase 3
36 Antimetabolites, Antineoplastic Phase 3
37 Pharmaceutical Solutions Phase 3
38 Anticoagulants Phase 3
39 Heparin, Low-Molecular-Weight Phase 3
40 calcium heparin Phase 3
41 Antimetabolites Phase 3
42 Fibrinolytic Agents Phase 3
43 Vasodilator Agents Phase 2, Phase 3
44 Antihypertensive Agents Phase 2, Phase 3
45 Anti-Arrhythmia Agents Phase 2, Phase 3
46 Adrenergic Antagonists Phase 2, Phase 3
47 Adrenergic beta-Antagonists Phase 2, Phase 3
48 Adrenergic Agents Phase 2, Phase 3
49 Central Nervous System Depressants Phase 3,Phase 2,Not Applicable
50 Tranquilizing Agents Phase 3,Phase 2,Not Applicable

Interventional clinical trials:

(show top 50) (show all 113)
# Name Status NCT ID Phase Drugs
1 On-label tReatment With Intravitreal Aflibercept injectiOn for Patients With Persistent Pigment epitheliaL Detachments in Neovascular Age Related Macular Degeneration (AMD) Unknown status NCT01670162 Phase 4 Aflibercept
2 Treatment Trial for Psychogenic Nonepileptic Seizures Completed NCT00835627 Phase 4 sertraline
3 Treatments for Psychogenic Nonepileptic Seizures (NES) Completed NCT00159965 Phase 4 sertraline;placebo
4 Intravitreal Aflibercept Injection for the Treatment of Submacular Vascularized Pigment Epithelial Detachment Completed NCT01722656 Phase 4 Aflibercept
5 Intravitreal Ranibizumab in Retinal Pigment Epithelial Detachments Completed NCT00976222 Phase 4 intravitreal injection with ranibizumab
6 Eylea to Treat Retinal Pigment Epithelial Detachment (RPED) Secondary to Wet Age-Related Macular Degeneration (wAMD) Completed NCT02142296 Phase 4 Eylea
7 Rasagiline (Azilect) - Neuroprotection for Macula-off Retinal Detachment Active, not recruiting NCT02068625 Phase 4 Rasagiline;Placebo
8 Triple Treatment for Detachment of Retinal Pigment Epithelium Secondary to Polypoidal Choroidal Vasculopathy Withdrawn NCT01666236 Phase 4
9 Pressurized PPV 23GA Vitrectomy in Complicated Diabetic Tractional Retinal Detachment Unknown status NCT00404209 Phase 3
10 Comparison High-Density Silicone Oils in Retinal Detachment Unknown status NCT00403702 Phase 2, Phase 3 Oxane HD [oil-RMN3-mixture];Densiron [(F6H8)
11 Surgical Management of Pseudophakic and Aphakic Retinal Detachment; a Randomized Clinical Trial Unknown status NCT00370279 Phase 3
12 Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment. Unknown status NCT02834559 Phase 3 5-fluorouracil and low molecular weight heparin;Placebo
13 A Novel Treatment For Chronic Posttraumatic Stress Disorder (PTSD) Using Post-Reactivation Propranolol Unknown status NCT01127568 Phase 2, Phase 3 Propranolol is available in generic form as the Wyeth product under the trade name Inderal.
14 Lucentis for Age-related Macular Degeneration Pigment Epithelial Detachments Completed NCT00590694 Phase 2, Phase 3 ranibizumab
15 Pre-Operative Intravitreal Bevacizumab for Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy Completed NCT01976923 Phase 3 Intravitreal bevacizumab
16 Rehabilitation of Conversion Gait Disorder Unknown status NCT01422278 Phase 1, Phase 2
17 Lucentis to Treat Pigment Epithelial Detachment Completed NCT00841581 Phase 2 Ranibizumab
18 Posterior Vitreous Detachment (PVD) Assessment During Dual Retinal Vein Occlusion (RVO) Lucentis Evaluations Completed NCT00831350 Phase 2 Ranibizumab
19 Body-Oriented Therapy for Sexual Abuse Recovery Completed NCT00097305 Phase 2
20 Ranibizumab for Diabetic Traction Retinal Detachment Completed NCT01201161 Phase 2 Ranibizumab
21 Pars Plana Vitrectomy (PPV) Versus Preoperative Intravitreal Bevacizumab Plus PPV to Treat Diabetic Tractional Retinal Detachment (IBETRA) Completed NCT00690768 Phase 2 Bevacizumab
22 Naltrexone in the Treatment of Dissociative Symptoms in Patients With Borderline Personality Disorder Completed NCT01133301 Phase 2 Naltrexone;Placebo
23 Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment Completed NCT00198471 Phase 2 Vitrase
24 Head Positioning After Retina Detachment Repair Recruiting NCT03714503 Phase 2
25 Study of Denufosol (INS37217) in Subjects With Rhegmatogenous Retinal Detachment Terminated NCT00083967 Phase 2 denufosol tetrasodium (INS37217) Intravitreal Injection
26 HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration Terminated NCT01189019 Phase 2 ranibizumab;ranibizumab
27 Flexibility, Efficacy, and Safety of a Foldable Capsular Vitreous Body in the Treatment of Severe Retinal Detachment Unknown status NCT01261533 Phase 1
28 A Study in Subjects With Retinal Detachment Completed NCT00210067 Phase 1 denufosol tetrasodium (INS37217) Intravitreal Injection
29 Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments Completed NCT00749021 Phase 1 Ranibizumab;Ranibizumab;Ranibizumab;Ranibizumab
30 Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment Completed NCT00548197 Phase 1 Bevacizumab
31 Ursodeoxycholic Acid for Rhegmatogenous Retinal Detachment Recruiting NCT02841306 Phase 1 Ursodeoxycholic Acid
32 A Study to Evaluate the Safety and Tolerability of ONL1204 in Patients With Macula-off, Rhegmatogenous Retinal Detachment Not yet recruiting NCT03780972 Phase 1 ONL1204
33 Psychotherapy and Pharmacotherapy in Dissociative Disorders Unknown status NCT00630981 Pharmacological treatment (Quetiapine and/or Escitalopram)
34 Psychopathology of Dissociative Disorders Unknown status NCT01388140
35 Cognitive Behavioural Therapy in Dissociative Seizures Unknown status NCT00688727 Not Applicable
36 Multi-electrocoagulation Retinectomy for Retinal Re-detachment in Silicone Oil Filled Eye Unknown status NCT02201706 Not Applicable
37 Double Endotamponade With Perfluorodecalin and Silicone Oil in Retinal Detachment Surgery. Unknown status NCT01959568 Not Applicable
38 Corneal Endothelial Cell Loss After Pneumatic Retinopexy for the Repair of Primary Rhegmatogenous Retinal Detachment Unknown status NCT02185469 Not Applicable sulfur hexafluoride (SF6)
39 Iray for Vascularized Pigment Epithelial Detachment (VPED) Secondary to Age Related Macular Degeneration Unknown status NCT01521819 Not Applicable Lucentis
40 Prevalence of Dissociative Disorders in Children Completed NCT01512641 Not Applicable
41 Cytokine Levels in Conversion Disorder Completed NCT00971360
42 Metabolic Anomolies Associated With the 6 Month Clinical Evolution of Patients Suffering From Motor Conversion Disorder Completed NCT02329626
43 Exploration of the Social Cognition in Adolescents With a Dissociative Disorder or Autism Spectrum Completed NCT01805128 Not Applicable
44 Emotional and Cognitive Self-regulation, an EEG Study Completed NCT02459340 Not Applicable
45 Feasibility Study of Physiotherapy for Functional Motor Symptoms Completed NCT02275000 Not Applicable
46 TMS and Attentional Bias in Functional Motor Disorder Completed NCT02102906 Not Applicable
47 Assessment of Adverse Events in a Naive Pediatric Population Treated With an Antipsychotic Completed NCT02007928 Not Applicable
48 Comparing Different Treatments in Reducing Dissociative Seizure Occurrence Completed NCT02325544 Not Applicable
49 Treatment of Functional Movement Disorders With Psychotherapy Completed NCT01778517 Not Applicable
50 Benefits of the Involvement of Nurses in Meetings Between Physicians and the Families of Patients in the ICU. Completed NCT01745406

Search NIH Clinical Center for Dissociative Disorder

Cochrane evidence based reviews: dissociative disorders

Genetic Tests for Dissociative Disorder

Anatomical Context for Dissociative Disorder

MalaCards organs/tissues related to Dissociative Disorder:

41
Brain, Amygdala, Testes, Pituitary

Publications for Dissociative Disorder

Articles related to Dissociative Disorder:

(show top 50) (show all 230)
# Title Authors Year
1
Psychological Dissection of Patients Having Dissociative Disorder: A Cross-sectional Study. ( 29403129 )
2018
2
The enemy in the mirror: self-perception-induced stress results in dissociation of psychological and physiological responses in patients with dissociative disorder. ( 29938011 )
2018
3
Disconnected - Impaired Interoceptive Accuracy and Its Association With Self-Perception and Cardiac Vagal Tone in Patients With Dissociative Disorder. ( 29997537 )
2018
4
Can the Trauma Symptom Inventory-2 distinguish coached simulators from dissociative disorder patients? ( 30024218 )
2018
5
Trauma-related altered states of consciousness in post-traumatic stress disorder patients with or without comorbid dissociative disorders. ( 30455853 )
2018
6
Reconsidering the autohypnotic model of the dissociative disorders. ( 29565750 )
2018
7
Differential Diagnosis between Anomalous Experiences and Dissociation Disorder Using the Dissociative Disorders Interview Schedule (DDIS). ( 30058948 )
2018
8
Predicting a dissociative disorder from type of childhood maltreatment and abuser-abused relational tie. ( 28318411 )
2017
9
Depersonalization and derealization in self-report and clinical interview: The spectrum of borderline personality disorder, dissociative disorders, and healthy controls. ( 27681414 )
2017
10
Awareness of identity alteration and diagnostic preference between borderline personality disorder and dissociative disorders. ( 27918876 )
2017
11
The self-report Dissociative Disorders Interview Schedule: A preliminary report. ( 27046770 )
2017
12
The role of clinical experience, diagnosis, and theoretical orientation in the treatment of posttraumatic and dissociative disorders: A vignette and survey investigation. ( 27673351 )
2017
13
Dissociative disorders in acute psychiatric inpatients in Taiwan. ( 28189923 )
2017
14
Diagnostic challenges leading to underdiagnosis of dissociative disorders. ( 28223813 )
2017
15
Self-Injury and Suicide Attempt in Relation with Trauma and Dissociation among Adolescents with Dissociative and Non-Dissociative Disorders. ( 28326115 )
2017
16
Six-year follow-up of the treatment of patients with dissociative disorders study. ( 28680542 )
2017
17
Revisiting the concept of severe mental illness: severity indicators and healthcare spending in psychotic, depressive and dissociative disorders. ( 28796557 )
2017
18
Engendered Responses to, and Interventions for, Shame in Dissociative Disorders: A Survey and Experimental Investigation. ( 28915146 )
2017
19
Treatment of dissociative disorders and reported changes in inpatient and outpatient cost estimates. ( 29038681 )
2017
20
Assessing therapeutic change in patients with severe dissociative disorders: the progress in treatment questionnaire, therapist and patient measures. ( 29163860 )
2017
21
Intimate Partner Violence Among Patients With Dissociative Disorders. ( 29295027 )
2017
22
Anti-NMDA receptor encephalitis presenting as an acute psychotic episode misdiagnosed as dissociative disorder: a case report. ( 29497677 )
2016
23
Assessment of complex dissociative disorder patients and simulated dissociation in forensic contexts. ( 28029435 )
2016
24
Relationship of cognitive function and adjustment difficulties among children and adolescents with dissociative disorder. ( 27114655 )
2016
25
Tracking down the footprints of bad paternal relationships in dissociative disorders: A diffusion tensor imaging study. ( 26566870 )
2016
26
Out of body, out of mind? An examination of out-of-body experiences and dissociative disorders. ( 27700804 )
2016
27
Role of mindfulness in dissociative disorders among adolescents. ( 28066012 )
2016
28
Dissociative, Depressive, and PTSD Severity as Correlates of Non-Suicidal Self-Injury and Suicidality in Dissociative Disorder Patients. ( 26211678 )
2015
29
Child Abuse and Neglect in Complex Dissociative Disorder, Abuse-Related Chronic PTSD and Mixed Psychiatric Samples. ( 26275087 )
2015
30
Hyperglycemia associated dissociative fugue (organic dissociative disorder) in an elderly. ( 26286620 )
2015
31
Dissociative disorder manifesting for underlying adolescent hemi-parkinsonism: New chronology for old mummies. ( 26189361 )
2015
32
Childhood Traumatic Experiences, Dissociative Symptoms, and Dissociative Disorder Comorbidity Among Patients With Panic Disorder: A Preliminary Study. ( 26011585 )
2015
33
Dissociative disorders and possession experiences in Israel: a comparison of opiate use disorder patients, Arab women subjected to domestic violence, and a nonclinical group. ( 25300648 )
2015
34
Treatment of complex dissociative disorders: a comparison of interventions reported by community therapists versus those recommended by experts. ( 25365637 )
2015
35
High psychiatric comorbidity in adolescents with dissociative disorders. ( 25385063 )
2015
36
Childhood maltreatment and intimate partner violence in dissociative disorder patients. ( 25279109 )
2014
37
An outpatient clinical study of dissociative disorder not otherwise specified. ( 24461163 )
2014
38
Dissociation, shame, complex PTSD, child maltreatment and intimate relationship self-concept in dissociative disorder, chronic PTSD and mixed psychiatric groups. ( 25451418 )
2014
39
Dissociative disorder due to Graves' hyperthyroidism: a case report. ( 24713328 )
2014
40
Reliability and validity of the Turkish version of the Structured Clinical Interview for DSM-IV Dissociative Disorders (SCID-D): a preliminary study. ( 24377970 )
2014
41
The impact of the therapeutic alliance on treatment outcome in patients with dissociative disorders. ( 24616755 )
2014
42
Lipid levels in dissociative disorders: effects of psychodynamic psychotherapy. ( 24711056 )
2014
43
Anxiety disorders, obsessive-compulsive and related disorders, trauma- and stressor-related disorders, and dissociative disorders in DSM-5. ( 24880507 )
2014
44
Dissociative symptoms and dissociative disorders comorbidity in obsessive compulsive disorder: Symptom screening, diagnostic tools and reflections on treatment. ( 25133142 )
2014
45
Dissociative disorders: between neurosis and psychosis. ( 25405051 )
2014
46
Chronic complex dissociative disorders and borderline personality disorder: disorders of emotion dysregulation? ( 26401297 )
2014
47
Dissociative disorder induced by clarithromycin combined with rabeprazole in a patient with gastritis. ( 23569151 )
2013
48
Personality assessment inventory profile and predictors of elevations among dissociative disorder patients. ( 24060036 )
2013
49
Folie A deux mixed dissociative disorder--a case report. ( 24309892 )
2013
50
Dissociative disorders in DSM-5. ( 23394228 )
2013

Variations for Dissociative Disorder

Expression for Dissociative Disorder

Search GEO for disease gene expression data for Dissociative Disorder.

Pathways for Dissociative Disorder

GO Terms for Dissociative Disorder

Sources for Dissociative Disorder

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....